NL-OMON29905尚未招募4 期
pharmacokinetics and toxicity of linezolid in MDR-TB patients - Linezolid in MDR-TB
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •attending physician initiates treatment with linezolid
排除标准
- •allergy for linezolid
研究者
相似试验
进行中（未招募）
不适用
Investigation of the blood levels of selected antibiotics in critically ill patients undergoing dialysisSepsis and acute renal failure (ARF) are pathological entities that commonly co-exist in patients admitted to intensive care. Antibiotic dosing in septic patients with ARF can be complicated and may result in either underdosing, causing treatment failure and antibiotic resistance, or overdosing resulting in drug toxicity. The aim of this study is to collect pharmacokinetic data for evaluating underdosing or overdosing of linezolid and meropenem in patients receiving renal replacement therapy.EUCTR2013-000899-16-DEDepartment of Pharmacy Unversitätsmedizin Mainz
进行中（未招募）
1 期
Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infectioThe study population will consist of a representative group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot complicated by osteomyelitis. Patients must be subjected to undergo surgical debridement and intravenous antimicrobial therapy.EUCTR2008-006153-41-ATMedical university Graz, Department of Plastic Surgery
进行中（未招募）
不适用
Target site pharmacokinetics of linezolid after single and multiple doses in diabetes patients with soft tissue infectiodiabetic patients with soft tissue infection, necessiting antibiotic therapyEUCTR2007-007958-54-ATDepartment of Clinical Pharmacology, Medical University of Vienna
进行中（未招募）
1 期
Pharmakokinetik von Linezolid bei Dialyse (pharmacokinetics of linezolid under dialysis) - LINUSEUCTR2006-002338-39-DEniversitätsklinikum Heidelberg15
已完成
1 期
Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB)Multi-Drug Resistant TuberculosisExtensively Drug Resistant TuberculosisNCT00691392Centers for Disease Control and Prevention26